Sugemalimab is a fully human, full-length monoclonal antibody of the immunoglobulin G4 (IgG4) subclass that targets programmed death ligand 1 (PD-L1). This antibody exhibits anticancer properties, making it particularly valuable for research into non-small cell lung cancer (NSCLC). Sugemalimab's specificity for PD-L1 enables it to modulate immune responses, which is critical for understanding tumor immune evasion mechanisms in NSCLC.
Sugemalimab is a fully human, full-length monoclonal antibody of the immunoglobulin G4 (IgG4) subclass that targets programmed death ligand 1 (PD-L1). This antibody exhibits anticancer properties, making it particularly valuable for research into non-small cell lung cancer (NSCLC). Sugemalimab's specificity for PD-L1 enables it to modulate immune responses, which is critical for understanding tumor immune evasion mechanisms in NSCLC.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
